“Glenmark Clotrimazole Cream Recall: Temperature Abuse Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/38194-glenmark-clotrimazole-cream-recall-temperature-abuse-risk. Based on FDA recall #D-1743-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1743-2019%22&limit=1).
The FDA announced on 2019-08-07 that Glenmark Pharmaceuticals Inc., USA voluntarily recalled Clotrimazole and Betamethasone Dipropionate Cream USP due to temperature abuse complaints resulting in a liquidy texture. The recall affects 31,224 tubes distributed nationwide.
How to tell if you have it
Brand: Glenmark
Product: Clotrimazole and Betamethasone Dipropionate Cream USP, 1%/0.05%
Size: 15 gram tubes
NDC: 68462-298-17
Lot #: 05180734
Expiration: 03/2020
Distribution: Nationwide within the United States
The hazard
The recall was initiated because complaints were received regarding a liquidy texture caused by temperature abuse, according to the FDA.
Context
GovInfoNow's records show Glenmark Pharmaceuticals Inc., USA has had 54 other recalls on record since 2017-11-20. Other recent recalls of similar products include Glenmark Azelaic Acid Gel 15% Recall (2026-07-23), Glenmark Alyacen Birth Control Tablets Recall (2026-05-27), and Glenmark Ondansetron Tablets Recall (2025-12-30). Other recent recalls of similar products include Blossom Globe Clotrimazole Cream Recall (2025-10-31), Blossom Pharmaceuticals Globe Clotrimazole Cream Recall (2025-10-31), and Medline Silicone Cream Recall (2026-06-11).
How to tell if you have this one
Check for 15-gram tubes labeled Clotrimazole and Betamethasone Dipropionate Cream USP 1%/0.05%. The product was manufactured by Glenmark with NDC 68462-298-17 lot number 05180734.
Brand
Glenmark
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Look for the NDC 68462-298-17 lot number 05180734 on the tube.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide with the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 15 months after the firm started it.
1Firm started the recall
2FDA classified it Class III
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-1743-2019 (August 7, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1743-2019 to see it in context.
Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.